When bacteria are growing or dividing, bonds must be cleaved in the murein layer to create sites for the insertion of new material into this macromolecule surrounding the cell. Among the various murein-metabolizing enzymes identified in Escherichia coli, only two glycan strand-degrading enzymes and two endopeptidases degrade the intact murein polymer in vitro (21) . The two glycan strand-degrading enzymes are also known as the lytic transglycosylases, the soluble lytic transglycosylase (Slt), with a molecular mass of 70 kDa, being compartmentalized in the periplasm (10, 49) , and the membrane-bound lytic transglycosylase (Mlt), with a molecular mass of approximately 35 kDa, described to be present in the cytoplasmic membrane as well as in the outer membrane of E. coli (19, 24, 37) . Both transglycosylases catalyze the cleavage of the P-1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine residues, an activity comparable to that of various lysozymes. However, the bacterial transglycosylases catalyze, in addition, an intramolecular transglycosylation reaction at the N-acetylmuramic acid residue, resulting in the formation of a 1,6-anhydro bond. This fact has led to the proposal that the transglycosylases may play an important role in the recycling of muropeptides in the periplasm during cell elongation and division (16) .
Studies on the interesting enzymatic activities of the lytic transglycosylases will contribute to a better understanding of the metabolism of murein. Furthermore, the lytic transglycosylases can be used for the production of pharmacologically active compounds via the specific degradation of murein (12) . 1,6-Anhydro-muropeptides have been shown to exhibit sleep-promoting activities (26, 33) and are released by some human pathogens, eliciting cytotoxic effects on * Corresponding author. ciliated epithelial cells in higher organisms (7, 36) . The slt gene, encoding the soluble lytic transglycosylase, was cloned (2) , and the nucleotide sequence was recently determined (10) . The enzyme was purified from an overproducing strain, and crystals of X-ray quality were obtained (10, 41) .
This study concerns the membrane-bound lytic transglycosylase, which was described to be associated with the cytoplasmic and outer membranes but to be active only when present in the outer membrane (19) .
In the present paper, we describe the cloning, nucleotide sequence, and controlled overexpression of the presumed mlt gene and propose, on the basis of the obtained data, that the deduced open reading frame does not encode the membrane-bound lytic transglycosylase but encodes a 37-kDa protein with an unknown function.
Nevertheless, in E. coli 122-1 (40) , which is chromosomally deficient in the slt gene, encoding the soluble lytic transglycosylase, each N-acetylmuramic acid end of the glycan strands is still of the 1,6-anhydro type (18a) , indicating the presence of a second transglycosylase in E. coli.
In E. coli, only the soluble lytic transglycosylase has been described as a glycan strand-degrading soluble murein hydrolase, being enzymatically active, in vitro, on the purified murein polymer, releasing low-molecular-weight 1,6-anhydro-muropeptides. Murein hydrolase activity was still detected in the soluble protein fraction of an E. coli strain that carries a chromosomal deletion of the slt gene. We describe the purification from this E. coli strain of a soluble murein hydrolase that has a molecular mass of approximately 35 kDa and that has in vitro enzymatic activity on the isolated murein polymer, releasing 1,6-anhydro-muropeptides. To avoid confusion, we designate the soluble lytic transglycosylases Slt7O and Slt35, in accordance with their respective molecular masses. Data suggesting that this second soluble lytic transglycosylase (Slt35) is identical to the previously reported membrane-bound lytic transglycosylase (Mlt) are presented.
MATERIALS AND METHODS
Plasmids, bacterial strains, and media. The E. coli gene library, established in the runaway replication vector pWK12, has been described (2) . Vectors M13mpl8 and M13mpl9 were those used by Vieira and Messing (46) . Phasmids pMa5-8 and pMc5-8 and plasmid pJRD187 have been described (8, 44) . Helper phage M13KO7 was obtained from Pharmacia LKB Biotechnology Inc., Uppsala, Sweden (47) . Strain CJ236 was purchased from Bio-Rad Laboratories, Richmond, Calif. E. coli 122-1, chromosomally deficient in the slt gene, encoding the soluble lytic transglycosylase, was obtained from Roeder and Sommerville (40) . Wild-type E. coli DSM1576 was purchased from DSM, Braunschweig, Germany. E. coli strains were grown in Luria-Bertani medium supplemented with the appropriate antibiotics (32 Radioactive labeling of the isolated murein polymer. Murein was isolated from wild-type E. coli DSM1576 as described previously (12) . The isolated murein was labeled with tritium in a manner similar to the procedure by which the BoltonHunter reagent is used to iodinate proteins (5) . The isolated murein (24 mg) was treated with N-succinimidyl[2,3-3H]propionate (37 MBq; specific activity, 3.40 TBq/mmol), which reacts with free amino groups in murein, which are present only on diaminopimelic acid, the third amino acid of the stem peptides of E. coli murein, leaving diaminopimelic acid 3H propionated. The reaction was performed with 0.1 M sodium borate buffer (pH 8.5) with stirring for 15 min. Unincorporated label was subsequently removed by several washes with water until the 15,000 x g supernatant was free of label. The 15,000 x g murein pellet was resuspended in water containing 0.02% NaN3 at a concentration of 1.3 ,ug/,ul. The specific activity of 3H-propionated murein was 7,500 cpm/nug of murein.
DNA isolation and transformation. Plasmid DNA was purified by cesium chloride-ethidium bromide density gradient centrifugation (32) . The alkaline extraction procedure was used to prepare small-scale plasmid DNA (3). E. coli host strains were transformed with plasmids as described previously (31 (11) . In addition, the BamHI site was converted to an Asp718 restriction site. Cloning of the presumed mlt gene in pHEMalO1 resulted in the 5.8-kb plasmid designated pHEMa300. Site-directed mutagenesis was performed exactly as described by Kunkel et al. (27) . For the incorporation of uridine, strain CJ236 was used as a host for plasmid pHEMa300; helper phage M13K07 was used for the production of single-stranded DNA (47) . The synthetic oligonucleotide 5'-TIfJTfff''l'l'lCGGIACCATGCTIT-3', carrying an Asp718 restriction site (underlined), was synthesized on a model 380B DNA synthesizer (Applied Biosystems, Warrington, United Kingdom) by Eurosequence (University of Groningen, Groningen, The Netherlands). The oligonucleotide was used to clone the gene of interest directly in-frame and downstream of the translation initiation signals of the phage lambda cro gene under the control of the phage lambda PR promoter being regulated by the thermosensitive c1857 repressor. The 0.2-kb Asp718 fragment was subsequently deleted, resulting in the 5.6-kb plasmid designated pHEMa3O1.
E. coli HB101 harboring pHEMalOl or pHEMa3O1 was grown at 28°C in 500 ml of Luria-Bertani medium containing 100 jig of ampicillin per ml. When the cultures had reached the mid-exponential growth phase (optical density at 600 nm = 0.4), the temperature was shifted to 42°C. Growth was continued for 1 h, and cells were collected by centrifugation (15 min, 4 ,000 x g, 4°C), resuspended in 10 ml of 10 mM Tris-maleate-NaOH buffer (pH 6.8), disrupted in a French press at 10,000 lb/in2 (homogenate), and centrifuged at 100,000 x g for 1 h. The soluble fraction and the pellet were subjected to further analysis, the latter being washed several times with the above-described buffer and ultimately resuspended in the same buffer containing 2% Triton X-100. A small volume of this suspension was centrifuged at 15,000 x g, resulting in a solubilized membrane fraction and an insoluble particulate fraction. Both fractions were assayed for murein hydrolase activity by use of the isolated murein labeled with [3H]propionate as a substrate. Host strain HB101 carrying vector pHEMalO1 served as a control. Murein hydrolase assay. Murein degradation was assayed by measuring the release of low-molecular-weight muropeptides from the radiolabeled murein polymer as described for the soluble lytic transglycosylase in the absence of Triton X-100 (1).
Isolation of soluble murein hydrolase. Soluble murein hydrolase was isolated from E. (optical density at 600 nm = 6.0), the cells were harvested by centrifugation in a continuous centrifuge. The yield from the fermentation was 870 g of cells (wet weight). A 450-g quantity of cells was resuspended in 10 mM Tris-maleateNaOH buffer (pH 6.8) at 1 g (wet weight) per ml, disrupted in a French press at 10,000 lb/in2, and centrifuged at 100,000 x g for 1 h. The soluble murein hydrolase was isolated from the soluble fraction. The soluble fraction (760 ml; 22.5 mg of protein per ml) was dialyzed against 10 mM Tris-maleateNaOH buffer (pH 6.8) and loaded onto a carboxymethylSepharose CL-6B column (volume, 500 ml) equilibrated with the same buffer. The murein hydrolase was eluted at a concentration of 0.3 M NaCl when a linear gradient of 0.01 to 0.6 M NaCl in the same buffer (total volume, 1 liter) was applied. After dialysis of enzymatically active fractions (95 ml; 0.65 mg of protein per ml) against 10 
Restriction map of plasmid pWK2579 and the strategy used for sequencing the presumed mlt gene. The subcloning is described in Results. The 1.7-kb SaII-PstI DNA fragment of plasmid pWK71, containing the complete mlt gene and a truncated C-terminal open reading frame, is shown. The two coding regions are indicated by thick bars. Initially, bases were determined from the Sall and PstI sites in one direction and from the HindII and BgiII sites in both directions (long solid arrows). To read bases that were not obtained from these fragments, we performed Bai31 exonuclease digestions from the Satl and PstI sites to produce fragments that allowed further reading (broken arrows). The two small solid arrows and the arrowheads indicate the direction of transcription. The origin of replication is indicated by ori, and bla indicates the P-lactamase gene; the other regions are derived from lambda ( in pWK2579), Tn3 ( in pWK11O), Rl (-), pBR322
( ), and the 1-galactosidase gene ( 11 CTGAACGTCCAGACGGTGTTTAGAAACGTTGATGCTCGGGATiTTTTTCCGCACCCAGGCAAACGCGCGCCATGGCTGCAACGGTTTCTGACGGATAC1-GCCCACGG GACTTGCAGGTCTGCCACAAMTCTTTGCAACTACGAGCCCTAAAAMAGGCGTGGGTCCGTTTGCGCGCGGTACCGACGTTGCCAAAGACTGCCTATGACGGGTGCC Protein analysis. The method of Bradford was used to determine the protein concentrations (6) . Proteins from the different fractions were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (29) . The proteins were either stained with Coomassie brilliant blue R-250 or transferred to nitrocellulose filters and stained immunochemically (4) with polyclonal antibodies raised previously against either the isolated Mlt or the penicillin-insensitive murein endopeptidase (MepA) (23, 24 with polyclonal antibodies raised against purified Mlt (19) . The presumed mlt gene was localized by subcloning fragments of the insert in pWK2579 either into the BamHI site of pWK12 (pWK110) or the multiple cloning site of pUC9 (pWK71) as shown in Fig. 1 . Plasmid pWK71 overexpressed the 35-kDa protein (data not shown).
To determine the complete nucleotide sequence of the presumed mlt gene, we subcloned subfragments of the 1.7-kb SalI-PstI fragment of pWK71 into M13 vectors and then sequenced them by the method of Sanger et al. (42) . The sequencing strategy is depicted in Fig. 1 (39) and membrane-associated helices (9) revealed that the 37-kDa protein possesses in its N-terminal half two putative transmembrane helices and one putative membrane-associated helix. The hydrophobicity plot along the amino acid sequence (28) is shown in Fig. 3 .
In addition, a 3' open reading frame was found in the opposite direction and encodes a truncated C terminus of 127 amino acid residues (Fig. 2) .
Promoter sequence and translation initiation and transcription termination signals. A possible promoter sequence was identified upstream of the coding region, as shown in Fig. 2 ; it showed significant similarity to -35 and -10 consensus promoter sequences and was classified as a medium-strength promoter sequence (17, 38) . A ribosome-binding site upstream of the translation initiation site and showing similarity to the consensus Shine-Dalgarno sequence was not found (43) . A putative transcription terminator structure was identified downstream of the translation termination site and consisted of a GC-rich stem of 7 bp and a loop of 5 bases, as shown in Fig. 2 .
Controlled overexpression of the presumed mi gene. An overproducing plasmid was constructed as described in Materials and Methods with plasmids pHEMalO1 and pWK71 (Fig. 4) . Because of the creation of the Asp718 restriction site, the N terminus of the native 37-kDa protein (MetGluThrLys) is converted to MetValProLys. A 500-fold overproduction was achieved 1 h after temperature induction (42°C) (Fig. 5, lane 3) . The degree of overproduction was estimated from Western blot analysis with various dilutions of the homogenates. The overproduced 37-kDa protein could be solubilized from the 15,000 x g pellet in 10 mM Tris-maleate-NaOH buffer (pH 6.8) containing 2% Triton X-100 (Fig. 5, lane 6) . However, upon overproduction, no increase in murein hydrolase activity was detected in either of the fractions containing the overproduced protein.
Purification of the second soluble lytic transglycosylase (Slt35). The purification of Slt35 is summarized in Table 1 . The increase in yield after the CM-Sepharose CL-6B column step in comparison with the yield from the soluble fraction might be explained by the presence of inhibitors in the soluble fraction. Therefore, the final purification (10,784-fold) and the final yield (21%) were in fact somewhat lower than calculated. The purification steps are shown in Fig. 6A the monomeric muropeptides, the HPLC profile was identical to the profile of murein degraded by Slt7O; all muropeptides were of the 1,6-anhydro type (Fig. 8) . The disappearance of all dimeric 1,6-anhydro-muropeptides and the corresponding increase in the amount of monomeric 1,6-anhydro-muropeptides indicate the presence of an endopeptidase that can cleave both types of cross-bridges (D-Ala-m-DAP and m-DAP-m-DAP) present in murein. This enzymatic activity has been ascribed to MepA, the penicillin-insensitive murein endopeptidase (23) . Western blot analysis and immunostaining of the Slt35 preparation with the MepA-specific antibodies revealed the presence of traces of MepA, an enzyme with a molecular mass of 30 kDa (Fig. 6B, lane 2 contains the coding region for the structural gene that supposedly corresponds to the membrane-bound lytic transglycosylase codes for a protein of 323 amino acids. Analysis of the primary structure revealed that the N-terminal half of the encoded protein has a hydrophobic character (Fig. 3) ; the amino acid sequence possesses two putative regions long enough to span the membrane as transmembrane helices (39) and one putative region that could function as a membraneassociated helix (9) . (25, 35) , suggesting that this insert might originate from one of the very few -gaps in this map.
Overexpression of the presumed mit gene. The 500-fold overproduction of the 37-kDa protein encoded by the presumed mlt gene after temperature induction did not lead to an increase in murein hydrolase activity in the cell homogenate, the soluble fraction, or even the Triton X-100 extract of the membrane fraction, in which the major portion of the overproduced protein was detected immunochemically. This same phenomenon was observed earlier when the protein was overproduced at a much lower level in experiments with runaway replication plasmid pWK2579 (19) . This result was explained by the finding that apparently only a given number of protein copies are inserted into the outer membrane and bind to murein, by which they might be activated or at least stabilized. The major portion of the overproduced protein, however, did not undergo this translocation and activation and was therefore detected in an inactive form in the cytoplasmic membrane.
Localization of the 37-kDa protein. Mlt has been reported to be localized in the inner membrane as well as in the outer membrane of E. coli (19) . All E. coli proteins localized in the outer membrane are, to our knowledge, translated as pre- proteins. As a consequence of transportation across the cytoplasmic membrane, the N-terminal signal peptide is cleaved off, a process that ultimately can result in the insertion of the protein into the outer membrane. However, primary structure analysis of the 37-kDa protein revealed that this protein does not possess an N terminus with the typical features of a signal peptide (48) . Furthermore, the murein hydrolase activity was associated, in the wild-type situation, predominantly with the outer membrane fraction (19) ; the calculated and previously experimentally determined isoelectric points of the translated 37-kDa protein and Mlt, respectively, differed significantly; and, upon overproduction, no increase in murein hydrolase activity was detected. Taking all these data into consideration, we question the earlier explanation and suggest that we are dealing with a gene that does not encode the membrane-bound lytic transglycosylase but rather a cytoplasmic membrane-bound protein with an unknown function. Since polyclonal antibodies previously raised against purified Mlt cross-reacted with isolated Slt35, we conclude that Slt35 was present in the Mlt preparation and was responsible for the detected murein hydrolase activity. Because of their very similar molecular masses, the two proteins could not be detected as separate bands on SDS-polyacrylamide gels. Unfortunately, by screening of a gene overexpression library with the polyclonal antibodies, the gene encoding the 37-kDa membranebound protein with an unknown function was isolated.
Is Slt35 identical to previously described Mit? The determination of the subcellular localization of soluble mureinmetabolizing enzymes expressed at low levels has been shown to be difficult (49) . Since these enzymes act on murein and murein is pelleted with membranes after the disruption of cells, the soluble murein-metabolizing enzymes can be purified from the soluble fraction as well as from the membrane fraction. Therefore, it is possible that Slt35 was present in the previously described Mlt preparation in addition to the membrane-bound 37-kDa protein with an unknown function. Copurified SIt35, but not the membrane-bound 37-kDa protein, could therefore have been responsible for the murein hydrolase activity detected in this preparation. This conclusion is supported by the finding that the polyclonal antibodies previously raised against the Mlt preparation cross-reacted with purified Slt35 (Fig. 6B, lane 1) . Therefore, we suggest that the second transglycosylase in E. coli is not membrane bound, as was stated earlier (19, 24, 37) . E. coli seems to possess, for all essential reactions to be catalyzed during murein metabolism, at least two enzymes with identical enzymatic activities (20) . The high-molecularweight penicillin-binding proteins (PBPs) 1A and 1B are both described as cytoplasmic membrane-bound murein-synthesizing transglycosylases and transpeptidases, PBP 4 and the penicillin-insensitive murein endopeptidase (MepA) are described as soluble DD-endopeptidases, PBP 5 and PBP 6 are described as cytoplasmic membrane-bound DD-carboxypeptidases, and now Slt7O and Slt35 are described as soluble lytic transglycosylases.
Slt70 has been described as an exo-enzyme in vitro, starting at the N-acetylglucosamine end of the glycan strand and proceeding towards 1,6-anhydromuramic acid (1). It will be of interest to determine whether S1t35 acts as an endoenzyme involved in the trimming of sugar chains after the polymerization process. Within 5 min after synthesis, the sugar chains are reduced in average length from 50 to 31 disaccharide units (14) . Since no corresponding release of muropeptides has been observed, the existence of an endotransglycosylase has been proposed.
The enormous difference in the molecular masses of the two soluble lytic transglycosylases may indicate that Slt70 possesses an additional function in comparison with SIt35. Some carbohydrate-degrading enzymes have been described to possess a second substrate-binding domain in addition to a catalytic domain. Such an idea may be supported by the finding that the N-terminal amino acid sequence of Slt35 shows similarity to a stretch of amino acids in the middle of the primary structure of Slt70 (Fig. 7B) . About 30% of the amino acid residues in a stretch of 26 amino acids are identical, and 54% are similar when evolutionarily related substitutions are included. Cloning of the gene encoding Slt35 and its nucleotide sequence as well as the determination of the three-dimensional structure of Slt70 (41) may prove this idea.
